Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

Similar articles for PubMed (Select 22612376)

1.

Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.

Kopylov U, Levin A, Mendelson E, Dovrat S, Book M, Eliakim R, Ben-Horin S.

Aliment Pharmacol Ther. 2012 Jul;36(2):145-50. doi: 10.1111/j.1365-2036.2012.05150.x. Epub 2012 May 22.

2.

Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.

Hackett CB, Wall D, Fitzgerald SF, Rogers S, Kirby B.

Br J Dermatol. 2011 Jun;164(6):1387-9. doi: 10.1111/j.1365-2133.2011.10315.x.

PMID:
21410679
3.

Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.

Naganuma M, Nagahori M, Fujii T, Morio J, Saito E, Watanabe M.

Inflamm Bowel Dis. 2013 Feb;19(2):418-22. doi: 10.1002/ibd.23027.

PMID:
22605673
4.

Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital.

Almuneef M, Dillon J, Abbas MF, Memish Z.

Am J Infect Control. 2003 Oct;31(6):375-81.

PMID:
14608306
5.

Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.

Wu MF, Yang YW, Lin WY, Chang CY, Soon MS, Liu CE.

J Hosp Infect. 2012 Feb;80(2):162-7. doi: 10.1016/j.jhin.2011.11.011. Epub 2011 Dec 19.

PMID:
22188630
6.

Varicella zoster virus infection in inflammatory bowel disease.

Cullen G, Baden RP, Cheifetz AS.

Inflamm Bowel Dis. 2012 Dec;18(12):2392-403. doi: 10.1002/ibd.22950. Epub 2012 Mar 20. Review.

PMID:
22434654
7.

Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.

Vandersmissen G, Moens G, Vranckx R, de Schryver A, Jacques P.

Occup Environ Med. 2000 Sep;57(9):621-6.

8.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
9.

Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.

Jenke AC, Klein S, Baiker A, Wirth S, Sander M, Noelting C, Boecher O, Vizoso-Pinto MG.

Pediatr Infect Dis J. 2012 Nov;31(11):1148-52. doi: 10.1097/INF.0b013e31826bac27.

PMID:
22863912
10.

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH.

J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x.

PMID:
21039834
11.

Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women.

Linder N, Ferber A, Kopilov U, Smetana Z, Barzilai A, Mendelson E, Sirota L.

Fetal Diagn Ther. 2001 Nov-Dec;16(6):423-6.

PMID:
11694750
12.

Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.

Koturoglu G, Kurugol Z, Turkoglu E.

Paediatr Perinat Epidemiol. 2011 Jul;25(4):388-93. doi: 10.1111/j.1365-3016.2010.01180.x. Epub 2011 Apr 3.

PMID:
21649681
13.

Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.

Nordgaard-Lassen I, Dahlerup JF, Belard E, Gerstoft J, Kjeldsen J, Kragballe K, Ravn P, Sørensen IJ, Theede K, Tjellesen L; Danish Society for Gastroenterology.

Dan Med J. 2012 Jul;59(7):C4480.

PMID:
22759856
14.

Varicella immunity in vaccinated healthcare workers.

Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS.

J Clin Virol. 2013 Jun;57(2):109-14. doi: 10.1016/j.jcv.2013.01.015. Epub 2013 Feb 20.

PMID:
23434396
15.

Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.

Ludwig B, Kraus FB, Allwinn R, Keim S, Doerr HW, Buxbaum S.

Infection. 2006 Aug;34(4):222-6.

PMID:
16896582
16.

Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.

Lafer MM, de Moraes-Pinto MI, Weckx LY.

Rev Inst Med Trop Sao Paulo. 2005 May-Jun;47(3):139-42. Epub 2005 Jul 12.

17.

Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.

Prelog M, Schönlaub J, Jeller V, Almanzar G, Höfner K, Gruber S, Eiwegger T, Würzner R.

Vaccine. 2013 May 7;31(20):2420-6. doi: 10.1016/j.vaccine.2013.03.058. Epub 2013 Apr 10.

PMID:
23583889
18.

Seroprevalence of varicella-zoster virus in Polish population.

Siennicka J, Trzcińska A, Rosińska M, Litwińska B.

Przegl Epidemiol. 2009;63(4):495-9.

19.

How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.

Kavaliotis J, Petridou S, Karabaxoglou D.

Int J Infect Dis. 2003 Dec;7(4):274-7.

20.

Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.

Chazan B, Colodner R, Teitler N, Chen Y, Raz R.

Am J Infect Control. 2008 Aug;36(6):436-8. doi: 10.1016/j.ajic.2007.06.004.

PMID:
18675150
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk